文献速递免疫规划卫生政策与健康促进

应用以人为本设计方法提高刚果民主共和国乔波省免疫覆盖率的成本分析

Applying a human-centered design approach to increase immunization coverage and reduce the number of zero-dose children in Tshopo Province, Democratic Republic of the Congo: A costing analysis.
PubMed 文献 · Vaccine · 2026-06-20

刚果民主共和国乔波省零剂次儿童比例超过60%,PATH与卫生部合作在四个卫生区实施以人为本设计项目。研究采用微观成本法评估以人为中心设计方法及原型干预的增量财务、机会和经济成本。将私营卫生机构纳入免疫活动后,每名接种Penta 1的零剂次儿童财务成本为16美元、经济成本为31美元;社区参与活动每识别一名零剂次儿童财务成本为10美元、经济成本为17美元。

要点

  • 私营卫生机构参与免疫活动每名零剂次儿童接种Penta 1的财务成本16美元、经济成本31美元
  • 社区参与活动每识别一名零剂次儿童财务成本10美元、经济成本17美元
  • 干预总体实施成本预计在设计测试和优化阶段完成后下降

核心结论

  • 以人为本设计衍生的方法可能为识别适应当地策略以提高儿童免疫覆盖率提供可行机制。

研究设计与样本

  • 研究采用微观成本法、基于投入要素的方法,记录并估值项目期间使用的所有资源。
  • 项目由PATH与刚果民主共和国卫生部合作,在乔波省四个目标卫生区共同创建并测试解决方案。

主要发现

  • 私营卫生机构参与免疫活动后,每名接种Penta 1的零剂次儿童财务成本为16美元、经济成本为31美元。
  • 社区参与活动每识别一名零剂次儿童财务成本为10美元、经济成本为17美元。
  • 干预的总体实施成本预计在初始设计、测试和优化阶段完成后下降。

关键数值与推荐

  • 乔波省零剂次儿童比例高于60%。
  • 每名零剂次儿童接种Penta 1的财务成本为16美元、经济成本为31美元。
  • 每识别一名零剂次儿童的财务成本为10美元、经济成本为17美元。

临床怎么用

  • 决策者可参考本成本数据评估以人为本设计方法的 economic viability 及扩大规模潜力。
  • 本成本数据可为与其他提高免疫覆盖率策略的比较提供基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Democratic Republic of the Congo (DRC) is among the countries with the highest number of zero-dose and under-immunized children in the world. Tshopo Province, located in the North-Central area of the country, is particularly impacted, with alarmingly low immunization rates and a proportion of zero-dose children higher than 60%. Innovative and targeted interventions are required to reach children missed by the immunization program. In collaboration with the DRC Ministry of Health, PATH implemented a human-centered design (HCD) project to co-create and test solutions that could help the community address the issue in four targeted health areas of Tshopo Province. As part of the project, we conducted a study to assess the incremental financial, opportunity, and economic costs of implementing the HCD approach and derived prototype interventions. The aim was to inform decision-makers and technical and financial partners about the economic viability of the HCD approach and its potential for scale-up, and to provide a basis for comparison with other strategies to improve immunization coverage. Using a microcosting, ingredients-based approach, we documented and valued all resources used during the project and reported cost per pre-defined activities and cost categories. Among the interventions implemented, the involvement of private health facilities in immunization activities resulted in a financial and economic cost per zero-dose child vaccinated with Penta 1 of US$16 and US$31 respectively; community engagement activities resulted in a financial and economic cost per zero-dose child identified of US$10 and US$17, respectively. The overall implementation costs of the interventions are expected to decrease after the initial design, testing, and refinement phrases are completed. Given these results, HCD-developed approaches may provide a feasible mechanism for identifying locally adapted strategies to improve childhood immunization coverage.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sanogo M, Tendo-Bugondo C, Abedi M, et al. Applying a human-centered design approach to increase immunization coverage and reduce the number of zero-dose children in Tshopo Province, Democratic Republic of the Congo: A costing analysis. Vaccine. 2026. PMID: 42322681. doi:10.1016/j.vaccine.2026.128874

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。